Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma
- GSK to present data from its innovative oncology portfolio at ESMO Congress 2019
- GSK announces positive headline results from the pivotal DREAMM-2 study for multiple myeloma
Tweets from GSK US
-
GSKUS @GSKUS
94% of #ovariancancer patients live longer than 5 years after diagnosis but only 20% of women are diagnosed in the early stages. This #OvarianCancerAwarenessMonth learn about early detection and common symptoms here: gsk.to/2ZP5Wid
about 2 days ago -
GSKUS @GSKUS
Proud to partner with @SavetheChildren in the US & around the globe. 🎉This year, they are commemorating 100 years of improving the lives of the most vulnerable children. bit.ly/2kH7EDKJtwitter.com/EmpireStateBld…lq
about 3 days ago
-
GSKUS @GSKUS
BREAKING #NEWS: FDA approves treatment for children as young as six-years-old living with severe eosinophilic asthma. gsk.to/2O0Nq43
about 3 days ago
